Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8248768 | 8485999 | I | 8248768-0 | 20120329 | 20120331 | EXP | PHHY2012BR026969 | NOVARTIS PHARMACEUTICAL CORPORATION | YR | F | Y | 20120330 | CN | BRAZIL |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
8248768 | 1019282817 | PS | EXELON | 1 | TRANSDERMAL | 9 MG/5 CM2 (4.6MG/24HOURS) | 022083 |
Indications of drugs used
no results found |
Outcome of event
Event ID | OUTC COD |
---|---|
8248768 | DE |
Reactions reported
Event ID | PT |
---|---|
8248768 | DEATH |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |